Literature DB >> 35860709

Guidelines for COVID-19 Laboratory Testing for Emergency Departments From the New Diagnostic Technology Team of the Taiwan Society of Emergency Medicine.

Chien-Chang Lee1, Yi-Tzu Lee2, Chih-Hung Wang1, I-Min Chiu3, Weide Tsai4, Yan-Ren Lin5, Chih-Huang Li6, Chin Wang Hsu7, Pei-Fang Lai8, Jiann-Hwa Chen9, Jeffrey Che-Hung Tsai10, Shih-Hung Tsai11, Chorng-Kuang How12.   

Abstract

COVID-19 tests have different turnaround times (TATs), accuracy levels, and limitations, which emergency physicians should be aware of. Nucleic acid amplification tests (NAATs) can be divided into standard high throughput tests and rapid molecular diagnostic tests at the point of care (POC). The standard NAAT has the advantages of high throughput and high accuracy with a TAT of 3-4 hours. The POC molecular test has the same advantages of high accuracy as standard high throughput PCR, but can be done in 13-45 minutes. Roche cobas Liat is the most commonly used machine in Taiwan, displaying 99%-100% sensitivity and 100% specificity, respectively. Abbott ID NOW is an isothermal PCR-based POC machine with a sensitivity of 79% and a specificity of 100%. A high rate of false positives and false negatives is associated with rapid antigen testing. Antibody testing is mostly used as part of public health surveys and for testing for immunity.

Entities:  

Keywords:  COVID-19 ; nucleic acid amplification testing ; point-of-care testing ; rapid point-of-care molecular testing

Year:  2022        PMID: 35860709      PMCID: PMC9283118          DOI: 10.6705/j.jacme.202206_12(2).0001

Source DB:  PubMed          Journal:  J Acute Med        ISSN: 2211-5587


  25 in total

1.  Point-of-care testing for the detection of SARS-CoV-2: a systematic review and meta-analysis.

Authors:  S H Yoon; S Yang; H Cho; S Eun; C M Koo; M K Kim
Journal:  Eur Rev Med Pharmacol Sci       Date:  2021-01       Impact factor: 3.507

2.  Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.

Authors:  Jonghoo Lee; Jae-Uk Song
Journal:  J Med Virol       Date:  2021-04-29       Impact factor: 2.327

3.  Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.

Authors:  Jacqueline Dinnes; Jonathan J Deeks; Sarah Berhane; Melissa Taylor; Ada Adriano; Clare Davenport; Sabine Dittrich; Devy Emperador; Yemisi Takwoingi; Jane Cunningham; Sophie Beese; Julie Domen; Janine Dretzke; Lavinia Ferrante di Ruffano; Isobel M Harris; Malcolm J Price; Sian Taylor-Phillips; Lotty Hooft; Mariska Mg Leeflang; Matthew Df McInnes; René Spijker; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2021-03-24

4.  Detection of IgM and IgG antibodies in patients with coronavirus disease 2019.

Authors:  Hongyan Hou; Ting Wang; Bo Zhang; Ying Luo; Lie Mao; Feng Wang; Shiji Wu; Ziyong Sun
Journal:  Clin Transl Immunology       Date:  2020-05-06

Review 5.  Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction: A Systematic Review and Meta-analysis.

Authors:  Joanna Merckx; Rehab Wali; Ian Schiller; Chelsea Caya; Genevieve C Gore; Caroline Chartrand; Nandini Dendukuri; Jesse Papenburg
Journal:  Ann Intern Med       Date:  2017-09-05       Impact factor: 25.391

6.  Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2.

Authors:  Hannah M Creager; Barbara Cabrera; Andy Schnaubelt; Jesse L Cox; Allison M Cushman-Vokoun; Salika M Shakir; Keith D Tardif; Meei-Li Huang; Keith R Jerome; Alexander L Greninger; Daria Drobysheva; Usha Spaulding; Margarita Rogatcheva; Kevin M Bourzac; S H Hinrichs; M J Broadhurst; P D Fey
Journal:  J Clin Virol       Date:  2020-07-06       Impact factor: 3.168

Review 7.  Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.

Authors:  Jayakanthan Kabeerdoss; Rakesh Kumar Pilania; Reena Karkhele; T Sathish Kumar; Debashish Danda; Surjit Singh
Journal:  Rheumatol Int       Date:  2020-11-21       Impact factor: 2.631

8.  Identification of bacterial co-detections in COVID-19 critically Ill patients by BioFire® FilmArray® pneumonia panel: a systematic review and meta-analysis.

Authors:  Tristan T Timbrook; Kyle D Hueth; Christine C Ginocchio
Journal:  Diagn Microbiol Infect Dis       Date:  2021-07-01       Impact factor: 2.803

9.  Comparison of Six SARS-CoV-2 Molecular Methods and Correlation with the Cycle Threshold Distribution in Clinical Specimens.

Authors:  Saravanan Raju; Neil W Anderson; Elizabeth Robinson; Crystal Squires; Meghan A Wallace; Ray Zhang; Carey-Ann D Burnham; Bijal A Parikh
Journal:  J Appl Lab Med       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.